Zobrazeno 1 - 10
of 1 084
pro vyhledávání: '"R, Colten"'
Autor:
Fontan JP; Department of Pediatrics, University of Texas Southwestern School of Medicine and Children's Medical Center of Dallas, TX 75390, USA., Dowton SB, Perlmutter D, Gitlin J, Cole FS
Publikováno v:
Pediatric research [Pediatr Res] 2006 Aug; Vol. 60 (2), pp. 231-2.
Autor:
Mark W. Mahowald
Publikováno v:
New England Journal of Medicine. 356:199-200
Autor:
Stephen Pincock
Publikováno v:
The Lancet. 370:478
Autor:
Institute of Medicine, Board on Health Sciences Policy, Committee on Sleep Medicine and Research, Bruce M. Altevogt, Harvey R. Colten
Clinical practice related to sleep problems and sleep disorders has been expanding rapidly in the last few years, but scientific research is not keeping pace. Sleep apnea, insomnia, and restless legs syndrome are three examples of very common disorde
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pincock, Stephen
Publikováno v:
In The Lancet 2007 370(9586):478-478
Autor:
H R Colten
Publikováno v:
Immunology today. 4(5)
The structure, organization and control of the expression of complement genes is now being studied at the RNA and DNA levels. This work was prompted by recognized genetic polymorphisms and complement deficiencies in humans and animals. Here Harvey Co
Autor:
Harvey R. Colten, Béla Z. Schmidt
Publikováno v:
Immunological Reviews. 178:166-176
The biological activities of the more than 30 proteins that comprise the complement system have been elucidated in parallel lines of investigation that resulted in the purification of the proteins and studies of their function in vitro. Twenty years
Autor:
Claude Libert, Bernardo Grijalba, Wim Van Molle, Elisabeth Kremmer, Peter Brouckaert, Harvey R Colten, Ben Wielockx, Walter Fiers
Publikováno v:
Cytokine. 11:617-625
Injection of tumour necrosis factor (TNF) in animals causes severe liver cell toxicity, especially when D-(+)-galactosamine (GalN) is co-administered. After challenge with TNF/GalN, serum complement activity (CH50 and APCH50) decreased dramatically,